A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) Bronchiectasis
PHASE1
CHF 6333 is a medicinal product on development for the treatment of cystic ...
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis
PHASE1
The aim of this clinical trial is to assess the safety of:
* single doses ...
Status
Recruiting
Location
Royal Papworth Hospital NHS Foundation Trust, Cambridge Centre for Lung Infection